Correction to: Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross‑sectional study
- PMID: 38127166
- DOI: 10.1007/s40266-023-01088-4
Correction to: Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross‑sectional study
Erratum for
-
Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross-sectional study.Drugs Aging. 2024 Jan;41(1):55-64. doi: 10.1007/s40266-023-01081-x. Epub 2023 Nov 13. Drugs Aging. 2024. PMID: 37957440
Publication types
LinkOut - more resources
Full Text Sources